Future Therapies in Multiple Myeloma

The future of bispecifics for myeloma: talquetamab combinationsПодробнее

The future of CAR-T and bispecifics in myeloma: successful integration into earlier linesПодробнее

Dr Biran on Future Research Directions in Multiple MyelomaПодробнее

Is CAR T Cell Therapy the Future for Multiple Myeloma Discover bb2121Подробнее

Bispecific antibodies in multiple myeloma: their current role and the futureПодробнее

The Future of Myeloma Care | New York Roundtable October 19, 2024Подробнее

The Future of Multiple Myeloma | Continuous collaboration: Patients, care partners, and specialistsПодробнее

The current and future management of myeloma in the second-lineПодробнее

Novel Immunotherapies in Relapsed/Refractory Multiple Myeloma: What Does the Future Hold?Подробнее

CAR-Ts in multiple myeloma: their current role and the futureПодробнее

What Is the Future for CAR-T in Multiple Myeloma?Подробнее

Hope for the Future in Black Myeloma- A Black Myeloma Health PanelПодробнее

Focusing on You: Multiple Myeloma Patient Has "Vision" for FutureПодробнее

Myeloma International Awareness DayПодробнее

Maintenance Therapy after a Transplant for Multiple MyelomaПодробнее

Frontline treatment of transplant eligible patients with myeloma: current approach & future changesПодробнее

How immunotherapies are changing the myeloma treatment landscape & future outlooksПодробнее

How CAR-T will impact the future of myeloma treatmentПодробнее

What Is the Role of Bispecific Antibody Therapies in Future Myeloma Care?Подробнее

EBMT Interview Spotlight Future Landscape of Multiple Myeloma Treatment Cell Therapy vs TransplantПодробнее